CG
PJP icon

Cutler Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cutler Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$1K – 5856
2021
Q4 		$1K Buy
+500
New +$39.5K ﹤0.01% 5095
2017
Q2 		– Sell
-2,200
Closed -$1K – 6904
2017
Q1 		$1K Buy
2,200
+300
+16% +$17.5K ﹤0.01% 5939
2016
Q4 		$1K Buy
+1,900
New +$109K ﹤0.01% 6102

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's PJP Position: Q1 2020 in Review

Cutler Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2020, closing a stake of 200 shares — an estimated $12K sold.

Cutler Group first reported a position in PJP in Q1 2016 and held it in 4 quarters. The position peaked at $127K in Q2 2016. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

  • Cutler Group reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 200 Invesco Pharmaceuticals ETF shares in Q1 2020, an estimated $12K.
  • Cutler Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 4 quarters.
  • Cutler Group's Invesco Pharmaceuticals ETF position peaked at $127K in Q2 2016.
  • 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.